Thus, a hypothesis to be tested is that obesity-induced falls in progesterone, especially if associated with increases in estrogen, decreases ArcN AT1R expression, and its ability to suppress NPY sympathoinhibition. The gene discussed is AGTR1; the disease is obesity due to melanocortin 4 receptor deficiency.